---
title: "MLSS: Q2 2026 revenue rose 22% year-over-year, but ongoing losses and cash constraints raise going concern risk"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295841095.md"
description: "Revenue grew 22% year-over-year in Q2 2026, driven by dental sales in China and early-stage medical segment growth. Operating loss narrowed to $1.1M, but going concern risk persists due to recurring losses and limited cash, despite a $1.5M private placement.Original document: Milestone Scientific, Inc. [MLSS] SEC 10-Q Quarterly Report — Aug. 14 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-13T20:19:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295841095.md)
  - [en](https://longbridge.com/en/news/295841095.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295841095.md)
generator: "portal-rs"
---

# MLSS: Q2 2026 revenue rose 22% year-over-year, but ongoing losses and cash constraints raise going concern risk

Revenue grew 22% year-over-year in Q2 2026, driven by dental sales in China and early-stage medical segment growth. Operating loss narrowed to $1.1M, but going concern risk persists due to recurring losses and limited cash, despite a $1.5M private placement.

Original document: Milestone Scientific, Inc. \[MLSS\] SEC 10-Q Quarterly Report — Aug. 14 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [MLSS.US](https://longbridge.com/en/quote/MLSS.US.md)

## Related News & Research

- [Milestone Scientific Q2 revenue rises 22% on medical segment growth, reaffirms 2026 outlook](https://longbridge.com/en/news/295928913.md)
- [Full Transcript: Milestone Scientific Q1 2026 Earnings Call](https://longbridge.com/en/news/286423291.md)
- [‘Far From Done,’ Says Top Investor About Sandisk Stock](https://longbridge.com/en/news/300141435.md)
- [Banca Popolare di Cortona buys 5% stake in Dometria](https://longbridge.com/en/news/300143901.md)
- [U.S. Investigation into CrowdStrike (CRWD) Ends with No Charges Being Filed](https://longbridge.com/en/news/300158337.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**